A PHASE II, RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND (SPONSOR OPEN) STUDY OF GSK1278863, A HIF-PROLYL HYDROXYLASE INHIBITOR, TO REDUCE ISCHEMIC EVENTS IN PATIENTS UNDERGOING THORACIC AORTIC ANEURYSM REPAIR

Registry ID

PPO116097

Source registry

HEALTH_CANADA

Status

Ongoing

Phase

PHASE2

Study type

INTERVENTIONAL

Sponsor

GLAXOSMITHKLINE INC

Start date

2013-12-24

Last update

2013-09-04

Conditions

• AORTIC ANEURYSM

Related clinical trials

• GALLIUM-DOTATATE PET-MR IMAGING TO DETECT MACROPHAGES IN ABDOMINAL AORTIC ANEURYSMS
• THE EFFECT OF TRANEXAMIC ACID IN RUPTURED ABDOMINAL AORTIC ANEURYSMS

View on source registry